Rocuronium in the myasthenic patient.
作者信息
Baraka A, Haroun-Bizri S, Kawas N, Hajjar A M, Kawkabani N
出版信息
Anaesthesia. 1995 Nov;50(11):1007. doi: 10.1111/j.1365-2044.1995.tb05904.x.
Abstract
摘要
相似文献
1
Rocuronium in the myasthenic patient.
Anaesthesia. 1995 Nov;50(11):1007. doi: 10.1111/j.1365-2044.1995.tb05904.x.
2
Rocuronium in two myasthenic patients undergoing thymectomy.
Acta Anaesthesiol Scand. 1997 Nov;41(10):1365-6. doi: 10.1111/j.1399-6576.1997.tb04659.x.
3
Fade of train-of-four ratio despite administration of more than 12 mg kg(-1) sugammadex in a myasthenia gravis patient receiving rocuronium.
Br J Anaesth. 2013 May;110(5):854-5. doi: 10.1093/bja/aet098.
4
Pharmacokinetic-pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: a study in myasthenic pigs.
Anesthesiology. 2003 Jan;98(1):133-42. doi: 10.1097/00000542-200301000-00022.
5
The use of sugammadex in a patient with myasthenia gravis.
Anaesthesia. 2010 Mar;65(3):302-5. doi: 10.1111/j.1365-2044.2009.06236.x. Epub 2010 Jan 23.
6
Possible abnormal response to rocuronium in a patient taking multiple fitness supplements.
Anaesth Intensive Care. 2016 Sep;44(5):640-1. doi: 10.1177/0310057X1604400520.
7
Rocuronium and rapid sequence induction.
Anaesthesia. 1995 Jul;50(7):663.
8
The interaction between mivacurium and rocuronium during onset and recovery.
Anaesthesia. 1997 Mar;52(3):279-80.
9
The interaction between mivacurium and rocuronium during onset and recovery.
Anaesthesia. 1997 Mar;52(3):280.
10
Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors.
Anesth Analg. 2002 Sep;95(3):588-96, table of contents. doi: 10.1097/00000539-200209000-00018.
Zotero 插件